Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-9705

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-9705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagram of venlafaxine hydrochloride, showing its molecular components including a cyclohexane ring, methoxy-substituted benzene ring, and a dimethylamino group.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A scatter plot chart showing fold change and 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of venlafaxine and ODV in various special populations, including hepatic impairment (cirrhosis, mild and moderate), renal impairment (mild/moderate and hemodialysis), CYP2D6 polymorphism metabolizer status, age over 60 years, and gender (female vs. male). The x-axis represents change relative to the reference value, ranging from 0 to 3.5, with data points clustered accordingly.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A pharmacokinetic chart showing fold change and 90% confidence intervals for venlafaxine and its metabolite ODV when co-administered with various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The chart plots changes in Cmax and AUC relative to reference values on the x-axis.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
A scatter plot chart showing the fold change and 90% confidence intervals for the pharmacokinetic (PK) parameters Cmax and AUC of various analytes when interacting with different drugs. The x-axis represents the change relative to the reference value, ranging from 0 to 3. Drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, with corresponding analytes and PK measures noted.*
FDA Label Image

Label (Lbl713359705)

Label (Lbl713359705)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 37.5 mg, containing 30 capsules. The label includes storage instructions, child-resistant packaging notes, and directs dispensing of the medication guide. It shows the NDC 71335-9705-1 and indicates the product is repackaged by Bryant Ranch Prepack and manufactured by Yichang Humanwell Oral Solid Dosage Plant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.